Lemaitre Vascular (LMAT) Total Liabilities (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Total Liabilities data on file, last reported at $222.9 million in Q1 2026.

• Quarterly Total Liabilities rose 6.94% year-over-year to $222.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $222.9 million (up 6.94% YoY) and the FY2025 annual result came in at $222.2 million, up 3.56% from the prior year.
• Total Liabilities was little changed at $222.9 million in Q1 2026 per LMAT's latest filing, from $222.2 million in the prior quarter.
• Across five years, Total Liabilities topped out at $222.9 million in Q1 2026 and bottomed at $34.7 million in Q1 2022.
• The 5-year median for Total Liabilities is $45.5 million (2024), against an average of $104.3 million.
• The widest annual swing landed in 2022, when Total Liabilities tumbled 50.37%; it then surged 393.5% in 2025.
• Tracing LMAT's Total Liabilities over 5 years: stood at $42.3 million in 2022, then advanced by 15.62% to $48.9 million in 2023, then jumped by 338.9% to $214.5 million in 2024, then increased by 3.56% to $222.2 million in 2025, then climbed by 0.33% to $222.9 million in 2026.
• Per Business Quant, the three latest LMAT Total Liabilities figures stand at $222.9 million (Q1 2026), $222.2 million (Q4 2025), and $219.1 million (Q3 2025).

Peer Comparison